Page 5 - மருந்தகங்கள் தானியங்கி விநியோகித்தல் இயந்திரங்கள் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்தகங்கள் தானியங்கி விநியோகித்தல் இயந்திரங்கள் சந்தை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்தகங்கள் தானியங்கி விநியோகித்தல் இயந்திரங்கள் சந்தை Today - Breaking & Trending Today

Pharmacies, GPs and private hospitals to help 163,000 people a day receive Covid-19 jabs


The second phase runs concurrently with phase 1, which prioritises the vaccination of about 1.2 million health workers. So far, nearly 300,000 health workers have received the jab.
Kingston said the government’s calculation is that the country across both public and private vaccination sites will need to vaccinate between 250,000 and 300,000 people per day in phase 2 to meet the 16.6 million target timeously.
The private sector rollout will be in close co-operation with and under the leadership of the national department of health, he said.
“Together we are stronger. We will move faster, further and more fairly. We must move together as a nation to achieve the goal of vaccinating as many people as quickly as possible with the objective of vaccinating the majority, if not all the adult population, by the first quarter of next year, if not before. ....

Covid Vaccination , Martin Kingston , Corona Virus , Covid 19 , Private Hospitals , மார்டின் கிஂக்ஸ்‌டந் , கொரோனா வைரஸ் , ப்ரைவேட் மருத்துவமனைகள் ,

Medicines regulator confirms J&J vaccine registration conditions restrict sale to state


Medicines regulator confirms J&J vaccine registration conditions restrict sale to state
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Only the national government can purchase and oversee the rollout of vaccines, bypassing the private sector
BL PREMIUM
13 April 2021 - 11:52 Tamar Kahn
SA’s medicines regulator has confirmed that one of the conditions attached to its approval of Johnson & Johnson’s (J&J)  Covid-19 vaccine restricts its sale to the national government, Business Day has learnt. 
This means that neither provincial governments nor private-sector entities, such as large employers or pharmacies, can buy directly from the vaccine manufacturer, even if it were willing to sell directly to them. J&J and several other vaccine manufacturers have previously indicated they will only sell to the national, but private-sector players have been hopeful that this position will sh ....

Itamar Kahn , National Health , Business Day , Financial Times , Sunday Times , Fatima Hassan , J Amp , Johnson Amp , Sa Health Products Regulatory Authority , Yuven Gounden , Health Justice Initiative , Private Sector , National Government , தாமரை கான் , தேசிய ஆரோக்கியம் , வணிக நாள் , நிதி முறை , ஞாயிற்றுக்கிழமை முறை , பாத்திமா ஹாசன் , ஜு ஆம்ப் , ஜான்சன் ஆம்ப் , தடுப்பு மருந்துகள் , ச ஆரோக்கியம் ப்ராடக்ட்ஸ் ஒழுங்குமுறை அதிகாரம் , யூவென் கௌந்தேன் , ஆரோக்கியம் நீதி முயற்சி , ப்ரைவேட் துறை ,